Citations

Mayo Clinic

Showing 10 of 108176 citations.

P2–194: Presymptomatic longitudinal decline in frontally mediated cognitive skills and memory in cognitively normal late middle aged APOE e4 carriers
Caselli, Richard J. , Hentz, Joseph G. , Osborne, David, Hoffman‐Snyder, Charlene , Alexander, Gene E. , Reiman, Eric M.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1032 Get It

P2–193: Progression of cognitive impairments in mild cognitive impairment: What is the next domain to be impaired after memory?
Pankratz, V. Shane , Ivnik, Robert J., Slusser, Tiffani C., Petersen, Ronald C. , Negash, Selam , Geda, Yonas E. , Knopman, David S. , Boeve, Bradley F. , Smith, Glenn E.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1031 Get It

P2–190: The prevalence of neuropsychiatric symptoms in normal aging and mild cognitive impairment: A population–based study
Rocca, Walter A. , Roberts, Rosebud O., Petersen, Ronald C. , Geda, Yonas E. , Knopman, David S.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1028 Get It

P2–186: Treatment of mild cognitive impairment with vitamin E and donepezil: Correlations between serial MRI and conversion, genotype, and treatment status
Thal, Leon J., Grundman, Michael, Ward, Chadwick P., Sencakova, Drahomira, Jin, Shelia , Gamst, Anthony, Petersen, Ronald C. , Group, The Alzheimer's Disease Cooperative Study, Jack, Clifford R. , Group, The Alzheimer's Disease Cooperative Study

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1024 Get It

P2–171: Clinical predictors of progression to Alzheimer's disease in amnestic mild cognitive impairment
Fleisher, Adam , Sowell, B. Brooke, Taylor, Curtis, Gamst, Anthony, Petersen, Ronald C. , Thal, Leon J.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1009 Get It

P2–164: Biochemical markers in blood and cerebrospinal fluid of persons with or at–risk for familial AD
Ringman, John M. , Cole, G. T., Geschwind, Daniel H. , Schaffer, Barbara, Rodríguez, Yaneth , Fein, Jeff, Medina, Luis D. , Praticò, Domenico , Younkin, Steven G., Cole, G T, Cummings, Jeffrey L. , Medina, Luis Daniel

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1002 Get It

S2–02–06: The tauopathies: From genetics to animal models
Hutton, Mike, Melquist, Stacey , Zehr, Cynthia, Eriksen, Jason L. , Stephan, Dietrich A. , Lewis, Jada , Baker, Matthew , McGowan, Eileen , Dickson, Dennis W. , Ashe, Karen H.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_1 | Pages: No page available

10.1016/j.jalz.2006.05.086 Get It

O1–03–02: In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques
Poduslo, Joseph F., Holasek, Silvina S., Ramakrishnan, M., Gilles, Emily J., Curran, Geoffry L., Wengenack, Thomas M., Ramı́rez-Alvarado, Marina

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_1 | Pages: No page available

10.1016/j.jalz.2006.05.045 Get It

PL–01–02: Genetics
Younkin, Steven G.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_1 | Pages: No page available

10.1016/j.jalz.2006.05.003 Get It

Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma
Lee, A S, Finkielman, Javier D., Peikert, Tobias, Hummel, Amber M., Viss, Margaret A., Jacob, G.L., Homburger, H A, Specks, Ulrich

Clinical and Experimental Immunology | August 16, 2006 | Volume: 146 | Issue: 1 | Pages: 15-20

10.1111/j.1365-2249.2006.03179.x | PMID 16968393 Get It

Summary Serum and plasma are used interchangeably to measure anti-neutrophil cytoplasmic antibodies (ANCA), even though the release of ANCA target antigens during the preparation of serum could affect ANCA assays and cause discrepancies between the results obtained from serum and plasma. To what extent ANCA test results obtained from serum agree and correlate with results from plasma remains unknown. Therefore, a comprehensive comparison was performed using serum and plasma samples which were collected in 175 patients with active Wegener's granulomatosis at enrolment of a recent randomized trial. These paired serum and plasma samples were subjected to parallel ANCA testing by standard indirect immunofluoresence on ethanol-fixed neutrophils, a direct enzyme-linked immunoassay (ELISA) for proteinase 3 (PR3)-ANCA and myeloperoxidase (MPO)-ANCA, and two different capture ELISAs for PR3-ANCA. The concordance of categorical serum and plasma ANCA results was assessed using κ-coefficients. These were > 0·8 for all assays, indicating a very good concordance between positive and negative serum and plasma results. Spearman's correlation coefficients for serum and plasma PR3-ANCA values obtained by direct ELISA and both capture ELISAs were ≥ 0·95 (P < 0·0001). Our study shows that serum and plasma samples can be used interchangeably for measuring ANCA.